4D Molecular Therapeutics, Inc 10-K for FY2021
4D Molecular Therapeutics, Inc. (FDMT)
10-K
2022-03-28
For: 2021-12-31
View Original
Added on
April 08, 2026
About this 10-K
4D Molecular Therapeutics, Inc filed this 10-K on March 28, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $18.04M
- up 32.5% from $13.61M a year earlier
- Net loss
- $71.32M
- compared with a net loss of $56.69M a year earlier